News
Locke Lord Strengthens Pharma, Biotech and Life Sciences Capabilities With Addition of 3 Lawyers to IP Pharma Practice Group
January 6, 2020
Locke Lord has added three lawyers in the Firm's IP Pharmaceutical Practice Group, further strengthening the Firm's well-recognized capabilities in intellectual property issues for life sciences companies.
Click here to read the complete PDF.
Don't miss a beat.
Sign up for our newsletter and get the latest to your inbox.
RELATED PROFESSIONALS
RELATED SERVICES
INDUSTRIES
Disclaimer
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.